Cancellation Fees
What it costs to stop, and what is refundable.
What it costs to stop, and what is refundable.
Across the 20 programmes we price, all-in cost runs from $145 a month at the starter dose, with the cheapest first year at about $1,740 (NexLife, $145 a month at a 2.4 mg maintenance dose). Every figure on this page is on that same all-in basis.
All-in monthly cost = medication + any recurring fee, at a named dose, before tax and before prepaid discounts. Captured 2026-08-05. How we verify a price.
All-in monthly cost at 2.4 mg
| Programme | All-in at 2.4 mg | First year | Per mg | Structure | Evidence |
|---|---|---|---|---|---|
| NexLife | $145 | $1,740 | $15.10 | flat at every dose | ✓ verified at source |
| Yucca Health | $146 | $1,752 | $15.21 | flat at every dose | third-party figure |
| Henry Meds | $149 | $1,788 | $15.52 | flat at every dose | third-party figure |
| OrderlyMeds ⚠ reports | $149 | $1,788 | $15.52 | flat at every dose | third-party figure |
| Join Fridays | $175 | $2,100 | $18.23 | flat at every dose | third-party figure |
| Mochi Health | $178 | $2,136 | $18.54 | flat at every dose | third-party figure |
| MEDVi | $179 | $2,148 | $18.65 | flat at every dose | ✓ verified at source |
| Hims & Hers | $199 | $2,388 | $20.73 | flat at every dose | third-party figure |
| Found | $199 | $2,388 | $20.73 | flat at every dose | third-party figure |
| LifeMD | $199 | $2,388 | $20.73 | flat at every dose | third-party figure |
| ShedRx | $199 | $2,388 | $20.73 | flat at every dose | third-party figure |
| TrimRx | $199 | $2,388 | $20.73 | flat at every dose | third-party figure |
| SkinnyRx | $199 | $2,388 | $20.73 | flat at every dose | third-party figure |
| IVIM Health | $224 | $2,688 | $23.33 | flat at every dose | ✓ verified at source |
| Amble Health | $225 | $2,700 | $23.44 | flat at every dose | third-party figure |
| Noom Med | $249 | $2,988 | $25.94 | flat at every dose | third-party figure |
| Eden | $295 | $3,540 | $30.73 | flat at every dose | third-party figure |
| Ro Body | $299 | $3,588 | $31.15 | flat at every dose | third-party figure |
| Remedy Meds | $299 | $3,588 | $31.15 | flat at every dose | third-party figure |
| Lavender Sky Health | $324 | $3,625 | $33.75 | rises with dose | ✓ verified at source |
What escalating the dose does to your bill
What to ask before you enrol
One question does most of the work: what will I pay in total in month six at 2.4 mg, including every fee? A programme that answers in one sentence has flat, all-inclusive pricing. A programme that needs three sentences has a structure worth reading carefully. A programme that cannot answer has told you something.
Then four more: which pharmacy fills the prescription, is the prescriber licensed in my state, does the quoted rate hold at renewal, and what is refundable before shipment.
Where these numbers come from
One dataset, captured 2026-08-05, with a verification status on every record. Prices we read at the provider are tagged as such; figures taken from third-party round-ups are tagged separately and treated as indicative. Where sources disagree we show the conflict rather than choosing. The whole file is downloadable.
Why this distinction changes what you pay
Every structural difference in this market resolves into money at a maintenance dose. Whether a programme charges a membership, whether it reprices with the dose, whether it demands a term, and whether it bundles or splits its charges together account for most of the gap between the cheapest tracked first year at $1,740 and the most expensive.
None of those differences is visible in an advertised headline figure, which is the reason this site exists in the form it does.
How to act on it this week
Price the dose you expect to maintain on rather than the starter dose. Add every recurring fee. Ask whether the quoted rate holds at renewal. Establish who compounds the medicine. And do not enter a prepaid term until you have held a maintenance dose for a cycle.
Those five steps take under an hour and reliably beat any amount of comparison reading, because they surface the information that comparison tables omit.
How this connects to what you will actually pay
Everything in this section resolves to one number: the all-in monthly cost at the dose you end up holding. Across the 20 programmes we price, that runs from $145 at the cheapest tracked route to several times that at the most expensive, for the identical molecule from the same category of licensed pharmacy.
4 of those programmes charge a recurring platform fee on top of medication and 19 hold one price at every strength. Those two facts explain most of the spread between advertised prices and real ones.
What we could verify and what we could not
4 of 32 tracked programmes have a price we read at the provider or manufacturer. The rest carry third-party figures we have not confirmed, or publish nothing we can interpret. Every table on this site marks which is which, and the comparison matrix lets you filter to verified prices only.
Where we have checked a third-party figure against a provider's own page, it has almost always moved — and it has moved upward. Promotional first months, prepaid bundle rates and medication-only figures that exclude memberships are all published as ongoing all-in prices. Assume an unverified figure is optimistic.
The regulatory distinction that sits under all of this
Compounded semaglutide is not FDA-approved. FDA does not review compounded preparations for safety, effectiveness or quality before they are marketed. The active molecule is the same as the branded product; the pre-market review is not, and the assurance comes instead from the pharmacy, the state board that licenses it and, at good operations, batch sterility and potency testing.
That is a legitimate framework rather than a loophole, and it is also why the price is lower. It puts more of the verification burden on the patient, which is the honest trade being made.
How this component moves the total
Across the 20 priced programmes, all-in cost at a maintenance dose spans $145 to $324. Most published comparisons explain that spread as differences in the medicine. It is not: the molecule is identical and frequently comes from the same category of licensed pharmacy.
It is overhead, clinical wrap, pharmacy sourcing and margin — plus the component this page isolates, which is invisible in a single headline figure.
The comparison this makes possible
Once each component is priced separately, two programmes with the same advertised number stop looking equivalent. 4 of 20 charge a mandatory recurring fee; 19 hold one price at every dose. A programme scoring badly on both can advertise the same figure as one scoring well on both.
That is why every table here states all-in cost at a named dose rather than a headline, and why some of our figures are higher than a programme's own homepage.
What to take from this page
One number to carry into any intake conversation: what you will pay in month six at 2.4 mg, including every fee. On the cheapest verified route that is $145. Anything materially below that band, from anyone, deserves the question of which of the four distortions is producing it.
The cost of stopping
Isolating notice periods and what is refundable is the only way two programmes with different structures become comparable. Without it you are ranking marketing decisions rather than costs.
The spread is not marginal. All-in cost at a 2.4 mg maintenance dose runs $145 to $324 across the 20 programmes we price — for the identical molecule, frequently from the same category of licensed pharmacy. Add the brand routes and the same active ingredient spans more than fifteenfold, from a roughly $149 oral option to a list price near $1,349.
The correction worth more than any negotiation: price the dose you expect to hold, add every recurring charge, and compare that figure. On the cheapest verified route it is $145 a month.
What a programme's answer here reveals
A programme that can state this component in one sentence has a simple structure and usually knows it is competitive. One that needs three sentences has a structure worth reading closely — not necessarily a worse deal, but a more conditional one.
One that cannot answer before an intake has made a commercial choice: it wants your contact details and a medical history before you can compare it against anything. That is legal and common, and it is why several programmes on this site carry a page explaining why we publish no figure for them.
Get the answer in writing. Almost every dispute in public complaint records for this category traces back to a number that was never put in an email.
Reading this alongside the rest of the site
Pricing pages isolate one component. Provider reviews carry the whole record for one programme. Comparisons run two side by side at every dose. The rankings sort the same dataset on different questions. None is the whole picture and none is meant to be.
If you read one other page, make it how to verify a pharmacy. Price is the easiest thing to compare and rarely the thing that goes wrong.
What we would need to change our mind
A programme publishing a figure at a dose tier currently blank. A named dispensing pharmacy with a checkable licence. A pricing model changing in either direction. A regulatory action. Or a correction from a reader with a source we can open.
All five are logged with the date they landed, on the change log and in the dataset. Prices here were captured 2026-08-05.
What this site will not do
Publish an estimated price for a programme that does not publish one. Rank a programme higher because it pays. Present a compounded preparation as equivalent to an approved product. Or carry a figure without the date it was captured.
Those four rules cost us pages, rankings and revenue, and they are the only reason a reader has to prefer this to a round-up assembled in an afternoon. A price without its date is not a fact, and a comparison built from undated prices is not a comparison.
Who this site is not for
Anyone with coverage under a documented indication, who should use it rather than read a cash comparison. Anyone looking for a source without a prescription, which this site will not help with. And anyone wanting a single confident recommendation, because the honest answer depends on your dose, your coverage and your tolerance for commitment.
If you want the short version anyway: price the dose you will hold, add every fee, verify the pharmacy, and avoid long prepaid terms until you have tolerated a maintenance dose for a cycle.
How much cancellation fees should weigh
Less than the dose question and more than the brand. 19 of 20 programmes hold one price from 0.25 mg to 2.4 mg; the rest reprice as you climb. Which group you choose changes a twelve-month total more than almost any other single decision.
That is because semaglutide titrates slowly. Sixteen weeks minimum to a maintenance dose, frequently longer for tolerability, and a dose-scaled programme reprices you at every step of it.
Flat pricing is worst value at the bottom of the ladder and best at the top, which makes it less a lower price than insurance against a decision your prescriber has not made yet.
What a well-run programme publishes
Its price at every strength. Its pharmacy. Its prescriber's licensure. Its cancellation notice period. And which form of the active ingredient it compounds from, because FDA has distinguished semaglutide base from salt forms and linked the salts to safety concerns.
That last one is specific to this molecule and almost never asked. Programmes that answer it precisely are telling you how closely they supervise their supply chain.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.